1. Home
  2. Labeler Index
  3. Synergy Health Ast, Llc
  4. 71161-114
  5. NDC Package Code: 71161-114-02 Lanreotide Acetate

NDC Package 71161-114-02 Lanreotide Acetate

Injection - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71161-114-02
Package Description:
1 POUCH in 1 CARTON / 1 SYRINGE in 1 POUCH / .2 mL in 1 SYRINGE
Product Code:
71161-114
Non-Proprietary Name:
Lanreotide Acetate
Substance Name:
Lanreotide Acetate
Usage Information:
This medication is a long-acting form of lanreotide. Lanreotide is used to treat a condition called acromegaly that occurs when the body makes too much of a certain natural substance called growth hormone. It is used when surgery or radiation treatment have not been fully successful or cannot be used. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Lanreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for acromegaly. It is used for the long-term treatment of this condition. This medication is also used to treat certain cancer or tumors of the stomach, intestines, or pancreas. It may help to slow down the growth of these tumors. Lanreotide is also used to treat carcinoid syndrome. It may help reduce the need to use another medication to treat diarrhea or flushing caused by carcinoid syndrome.
11-Digit NDC Billing Format:
71161011402
Product Type:
Drug For Further Processing
Labeler Name:
Synergy Health Ast, Llc
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Active Ingredient(s):
  • LANREOTIDE ACETATE 60 mg/.2mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    11-14-2007
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71161-114-02?

    The NDC Packaged Code 71161-114-02 is assigned to an UNFINISHED drug package of 1 pouch in 1 carton / 1 syringe in 1 pouch / .2 ml in 1 syringe of Lanreotide Acetate, drug for further processing labeled by Synergy Health Ast, Llc. The product's dosage form is injection and is administered via form.

    Is NDC 71161-114 included in the NDC Directory?

    Yes, Lanreotide Acetate is an UNFINISHED PRODUCT with code 71161-114 that is active and included in the NDC Directory. The product was first marketed by Synergy Health Ast, Llc on November 14, 2007 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71161-114-02?

    The 11-digit format is 71161011402. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271161-114-025-4-271161-0114-02